申请人:Abbott Laboratories
公开号:US05068251A1
公开(公告)日:1991-11-26
Compounds of the formula: ##STR1## wherein A is CH.sub.2 ; n is 0 or 1; R.sub.1 and R.sub.2 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, aralkyl and cycloalkyl; Z is the residue from a non-steroidal anti-inflammatory carboxylic acid compound; and M is a pharmaceutically acceptable cation or a metabolically cleavable group; and the pharmaceutically acceptable salts thereof; and a non toxic pharmaceutically acceptable carrier. These compounds are useful as inhibitors of 5-lipoxygenase.
该公式化合物:##STR1## 其中A为CH.sub.2;n为0或1;R.sub.1和R.sub.2分别选自氢、烷基、烯基、芳基烷基和环烷基组成的基团;Z为非甾体抗炎羧酸化合物的残基;M为药学上可接受的阳离子或代谢可裂解基团;以及其药学上可接受的盐;以及无毒的药学上可接受的载体。这些化合物可用作5-脂氧化酶的抑制剂。